Search results for: Health Policy and Regulation
Filter search results
Five unanswered questions from the UK’s Renewed Women’s Health Strategy
16 September 2026
…Renewed Strategy is explicit that health outcomes for women must improve. This ambition is clear, and reiterated by Baroness Merron, Minister for Women’s Health and Mental Health in her foreword: …
Analysing Global Immunisation Expenditure
15 April 2025
…and finance policymakers can build resilient healthcare systems that deliver long-term health and economic benefits. Immunisation is not only an effective health care intervention but a strategic investment in national…
OHE Graduate School
…financed and delivered, how medicines are developed and the effects and benefits of health to people and society: you should apply. And if you have studied economics, there’s a whole…
Two numbers, one decision: making climate-health valuation usable across sectors
18 May 2026
…distribution of who gains and who loses, across countries and across generations, is contested in both the welfare-economic and health-economic traditions and was left unresolved by the Delphi, as described…
The value of cell and gene therapies to the UK economy
20 October 2025
…satisfy both health and industrial strategy objectives. The analysis may also inform payment and risk-sharing mechanisms to help align incentives between the Treasury and the NHS. For industry, aggregate demand signals…
Efficiency Measurement in Primary Care: Time to Overcome the Challenges and Achieve Some Gains
10 March 2021
…and Alderwick, H., 2019. Understanding primary care networks. https://www.health.org.uk/publications/reports/understanding-primary-care-networks NHS England. General Practice Forward View. 2016. Available from: https://www.england.nhs.uk/wp-content/uploads/2016/04/gpfv.pdf Smith, P.C., 2009. Measuring value for money in healthcare: concepts and…
Prevention in the NHS 10 Year Health Plan: Promise, limits, and the path forward
17 September 2025
…poor uptake – only 32.4% received influenza vaccines in 2024 . This is despite healthcare workers witnessing first hand the impact of low vaccine rates and the strain on already overburdened health…
Estimating the Impact of U.S. Drug Price-setting Policies on Innovation Is Challenging, Even for the Congressional Budget Office
22 June 2022
…R&D and the risks in drug development is a challenging task. Peer-reviewed literature documenting the relationship between industry revenues and drug development is limited and outdated. And the R&D ecosystem…
Ethical Goals and Design Criteria for ‘Fair Access” to Drugs in the US Health Care System
31 March 2021
…organisations and health benefit consultants. Representatives from patient organisations and clinical speciality societies joined senior policy leaders from 25 payer and life science companies at a 2-day ICER Policy Summit…